Skip to content

Public FDA record

Z-0683-2019: Medtronic MiniMed 630G 6025805-003_C, Rx Only Medtronic MiniMed 670G 6025805-005_B, Rx Only Medtronic M

Recall record Z-0683-2019 for Medtronic Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0683-2019
Company in FDA record
Medtronic Inc.
FDA record creation date
Dec 22, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Reports of occurrences in which insulin pumps with version 4.10 software have failed to make expected audio sounds during alerts, alarms or sirens. This could cause a user to miss system notifications, alarms or sirens associated with how the pump is working, and with high and low glucose alerts.

Source facts

Action
On 10/3/2018, the firm sent an URGENT FIELD SAFETY NOTIFICATION to customers and distributors via email and/or US Postal Service First Class to inform them of reports of occurrences in which insulin pumps with version 4.10 software has failed to make expected audio sounds during alerts, alarms, or sirens. This failure could either cause the alarm volume to be stuck at a 4 (out of 5) level regardless of the personal setting, or it could make no sound. Either of these occurrences could cause the user to miss system notifications, alarms or sirens associated with how the pump is working, and with high and low glucose alerts. Consignees are being informed that they are receiving this letter because the firm's records indicate they may have one of the potentially affected insulin pumps. The notification further explains, this issue occurs when a specific electronic component in the pump malfunctions. This potential loss of audio could delay the user's response to the underlying reason for the alert, alarm, or siren, which could then lead to possible health and safety risks such as hypoglycemia or hyperglycemia. If this issue occurs with the pump, the audio cannot be permanently repaired or regained. The only way to permanently regain the audio capabilities is to exchange the affected pump with a replacement. Even if the pump has the audio issue, it will continue to deliver insulin as expected. Loss of the Vibrate feature has not been reported to occur as part of the above audio failure mode. If a customer has a pump that contains the specific electronic component, and the pump passes the Audio Beep test described below, there is still a chance that the pump may lose its audio capabilities at some future date. Customers are instructed to: What you should do: 1. If you have not already done so, enable the Vibrate feature on your pump. Even if the Audio Beep test passes, you should enable the Vibrate feature (in addition to your Audio feature) since it will add
Initiated
2018-10-03
Root cause
Software design (manufacturing process)
Distribution
US: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, VT, SC, SD, TN, TX, UT, VA, Virgin Island, VT, WA, WI, WV, and WY
Recall number
Z-0683-2019
Recall status
Open, Classified
CDRH record ID
167920
FDA record created
2018-12-22
Recall event number
81246

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗